Launch of Vasofran tablets, a differentiated treatment for hyperlipidemia
KyungDong Pharm launched Vasopran Tablet, a safe hyperlipidemia treatment, in October 2001.
Vasopran tablets are HMG CoA reductase inhibitors and effectively inhibit cholesterol synthesis. Vasopran tablets are an excellent hyperlipidemia treatment that significantly improves the lipid environment in the serum by lowering total cholesterol, LDL cholesterol, and triglycerides and increasing HDL cholesterol.
Additionally, unlike other agents, Vasofran is water-soluble, so it can be safely used clinically.
| Vasofran Jeong |
|
● Ingredients/Content ●Efficacy/Effectiveness ●Packing unit |